Blauvelt, A., Strober, B., Langley, R., Kavanagh, S., Arendt, C., Boehnlein, M., Lebwohl, M., & Reich, K. (2019). Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). SKIN The Journal of Cutaneous Medicine, 3, S39. https://doi.org/10.25251/skin.3.supp.39